๐Ÿ‡บ๐Ÿ‡ธ FDA

Intelligence ยท Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors โ€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ€” searchable for business development and competitive intelligence.

226 results for โ€œPfizerโ€ Clear

  1. A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

    Bristol-Myers Squibb / Pfizer EEIG

    Advanced or metastatic solid tumors, Gastroesophageal cancer (GEC), High grade serous ovarian cancer (HGSOC), Endometrial cancer (EC), Advanced or metastatic breast cancer, Platinum-resistant ovarian cancer (PROC)

    phase 1 other active

    1 trial
  2. A Phase 1 Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases

    Bristol-Myers Squibb / Pfizer EEIG

    Systemic Sclerosis, Idiopathic Inflammatory Myopathy, Rheumatoid Arthritis, Systemic Lupus Erythematosus

    phase 1 other active

    1 trial
  3. A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants

    Pfizer Ireland Pharmaceuticals Unlimited Company

    (HR) -positive human epidermal growth factor receptor 2 (HER2) -negative breast cancer (BC), non-small cell lung cancer (NSCLC), ovarian cancer, and triple negative breast cancer (TNBC)

    phase 1 other active

    1 trial
  4. A Phase 1/1b First-in-Human Study of BMS-986506 in ccRCC

    Bristol-Myers Squibb / Pfizer EEIG

    Advanced Clear Cell Renal Cell Carcinoma

    phase 1 other active

    1 trial
  5. A Phase I Study of BMS-986497 alone or in combination with Azacitidine (Aza) and Azacitidine plus Venetoclax (AZA+VEN) in relapsed or refractory (R/R) AML or MDS

    Bristol-Myers Squibb / Pfizer EEIG

    Acute Myeloid Leukemia and Myelodysplastic Syndrome

    phase 1 other active

    1 trial
  6. A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497

    Pfizer Ireland Pharmaceuticals Unlimited Company

    small cell lung cancer (SCLC), castration resistant prostate cancer (CRPC), follicular lymphoma (FL)

    phase 1 other active

    1 trial
  7. A Study of PF-08046031 in Adults With Advanced Melanoma and Other Solid Tumors

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Melanoma (or) malignant melanoma Non-small cell lung cancer Head and neck squamous cell carcinoma Esophageal cancer

    phase 1 other active

    1 trial
  8. A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Migraine with or without aura

    phase 1 other active

    1 trial
  9. A Study to Establish the Bioequivalence of Free Acid Tafamidis 61 mg Capsule and Tablet, and Evaluate the Safety and Tolerability of the 61 mg Tablet in Healthy Adults Under Fed Conditions

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Transthyretin amyloidosis

    phase 1 other active

    1 trial
  10. A Study to Learn About How Different Formulations of the Medicine Called Mevrometostat are Taken up Into the Blood in Healthy Adult Participants

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Small cell lung cancer, Castration-resistant prostate cancer, Follicular lymphoma

    phase 1 other active

    1 trial
  11. A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in healthy adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

    phase 1 other active

    1 trial
  12. A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Inflammatory bowel disease

    phase 1 other active

    1 trial
  13. A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Older adults at risk of malnutrition

    phase 1 other active

    1 trial
  14. A Study to Learn How Different Amounts of the Study Medicine Called PF-07293893 are Tolerated and Act in the Body of Healthy Adults.

    Pfizer Ireland Pharmaceuticals Unlimited Company

    heart failure with preserved ejection fraction

    phase 1 other active

    1 trial
  15. A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 are Tolerated and Act in the Body in Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Heart failure

    phase 1 other active

    1 trial
  16. A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Clonal hematopoiesis

    phase 1 other active

    1 trial
  17. A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults.

    Pfizer Ireland Pharmaceuticals Unlimited Company

    clonal hematopoiesis

    phase 1 other active

    1 trial
  18. A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 are Tolerated and Act in the Body in Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    IgA nephropathy

    phase 1 other active

    1 trial
  19. A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 are Tolerated and Act in the Body in Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    CCI

    phase 1 other active

    1 trial
  20. A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 are Tolerated and Act in the Body of Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Rheumatoid arthritis and Systemic Lupus Erythematosus

    phase 1 other active

    1 trial
  21. A Study to Learn How Different Forms of The Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Primary and secondary hypertension, and heart failure

    phase 1 other active

    1 trial
  22. A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropinยฎ (somatropin) Delivery and Taken Up Into the Blood in Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Growth hormone deficiency

    phase 1 other active

    1 trial
  23. A Study to Learn How a Tablet Compared with an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up into the Blood in Healthy Adults.

    Pfizer Ireland Pharmaceuticals Unlimited Company

    ER+/HER2- breast cancer

    phase 1 other active

    1 trial
  24. A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up into the Blood of Healthy Adults After Taking Different Tablets of the Study Medicine Called Ibuzatrelvir.

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Coronavirus disease 2019

    phase 1 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1โ€“3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources